EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
2024 · Journal of Hepatology · 1,232 citations
https://doi.org/10.1016/j.jhep.2024.04.031
V
Vlad Ratziu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
148
Papers
8.9K
Citations
34
h-index
48
i10-index
Vlad Ratziu is an academic researcher. The author has contributed to research in topics: Liver Disease Diagnosis and Treatment & Diet, Metabolism, and Disease & Liver Diseases and Immunity. The author has an h-index of 34, co-authored 126 publications.
ORCID: 0000-0002-3051-0111Papers by this author
worksObeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
2019 · The Lancet · 1,172 citations
https://doi.org/10.1016/s0140-6736(19)33041-7
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
2019 · The Lancet · 1,172 citations
https://doi.org/10.1016/s0140-6736(19)33041-7
Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis
2025 · New England Journal of Medicine · 468 citations
https://doi.org/10.1056/nejmoa2413258
Platform trials to overcome major shortcomings of traditional clinical trials in non-alcoholic steatohepatitis? Pros and cons
2022 · Journal of Hepatology · 22 citations
https://doi.org/10.1016/j.jhep.2022.09.021
The scaffold-dependent function of RIPK1 in experimental non-alcoholic steatohepatitis
2022 · Journal of Molecular Medicine · 5 citations
https://doi.org/10.1007/s00109-022-02217-z
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat